1 min read.Updated: 21 Feb 2022, 03:40 PM ISTLivemint
For the purpose, the govt is partnering with Panacea and the CEPI, which will provide funding of up to $12.5 million
Listen to this article
The government of India will partner with pharma company Panacea Biotec and the Coalition for Epidemic Preparedness Innovations (CEPI) to develop vaccine candidates to provide broad protection against SARS-COV-2 variants and other betacoronaviruses, a release stated on Monday.
Recommended For You
Select your Category
Internet Not Available
Wait for it…
Log in to our website to save your bookmarks. It'll just take a moment.